ISSN:

Journal Home

Blood and Lymphatic Cancer: Targets and Therapy Unclaimed

Dove Medical Press United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Blood and Lymphatic Cancer: Targets and Therapy is a journal indexed in SJR in Hematology and Oncology with an H index of . It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1602 €. The scope of the journal is focused on lymphoma, anticancer agents, haematology, leukaemia. It is published in English.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (-) Hematology (-) Oncology (-)

Price

1602 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Blood and Lymphatic Cancer: Targets and Therapy

-

SJR Impact factor

-

H Index

-

Total Docs (Last Year)

-

Total Docs (3 years)

-

Total Refs

-

Total Cites (3 years)

-

Citable Docs (3 years)

-

Cites/Doc (2 years)

-

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Hematology and Oncology Q1
Blood Q1
Blood Cancer Journal Q1
The Lancet Haematology Q1
Leukemia Q1

Compare this journals

Aims and Scope

Lymphoma Anticancer agents Haematology Leukaemia

FAQS